More than 1,200 mothers and 900 children impacted by Dutch fertility scandal The clinic admitted to using sperm from mass donors for over a decade in an ‘appalling’ case The Independent UK · Jun 9, 2025
McKesson Stock: Is Wall Street Bullish or Bearish? As McKesson has outpaced the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects. Barchart · May 22, 2025
Here's What to Expect From McKesson's Next Earnings Report McKesson is expected to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit growth. Barchart · Apr 24, 2025
3 Safe Dividend Stocks as Investors Seek to Reset Diversification Investors have been reminded that low growth is better than no growth; here are three dividend stocks that can provide shelter in the current storm MarketBeat · Apr 14, 2025
Is Cencora Stock Outperforming the Nasdaq? As Cencora has outperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects. Barchart · Mar 12, 2025
3 Stocks to Consider With a Possible Recession on the Table As recession indicators begin to flash, investors may turn to defensive plays for protection—these three stocks offer a compelling case for sturdiness. MarketBeat · Mar 10, 2025
Is McKesson Stock Outperforming the Dow? As McKesson has outperformed the Dow Jones over the past year, analysts are bullish about the stock’s prospects. Barchart · Mar 8, 2025
These 3 Stocks Are Generating Massive Returns on Capital Take a gander at these three stocks that are generating returns on invested capital (ROIC) that are among the best in the U.S. large-cap stock universe. MarketBeat · Feb 27, 2025
McKesson Stock: Analyst Estimates & Ratings McKesson has underperformed relative to the S&P 500 Index over the past year, but Wall Street analysts remain bullish on its growth prospects. Barchart · Feb 22, 2025
3 Healthcare IT Stocks Revolutionizing Patient Care With healthcare rapidly evolving through digital transformation, the demand for smarter, more efficient solutions is rising, and companies driving this shift are poised for significant upside. Therefore, investors might find opportunities in fundamentally strong healthcare IT stocks like Medtronic (MDT), McKesson Corp. (MCK), and Embecta (EMBC). Read more…. StockNews.com · Feb 19, 2025
Earnings Preview: What To Expect From McKesson's Report McKesson is expected to announce its third-quarter results next month, and analysts predict a single-digit growth in the company’s bottom-line figure. Barchart · Jan 15, 2025
Is Cencora Stock Underperforming the S&P 500? Cencora has trailed the S&P 500 index over the past year, but analysts remain highly bullish about the stock’s prospects. Barchart · Dec 22, 2024
Is McKesson Stock Underperforming the Nasdaq? Although McKesson has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects. Barchart · Dec 9, 2024
Do Wall Street Analysts Like McKesson Stock? McKesson has exceeded the broader market's performance over the past year, and Wall Street analysts are highly positive about the stock's outlook. Barchart · Nov 25, 2024
StockNews.com · Nov 12, 2024 3 Undervalued Health-Tech Stocks to Buy for Long-Term Growth The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical areas, as well as the demand for personalized medicine. Thus, it could be wise to invest in fundamentally solid health-tech stocks McKesson (MCK), Cardinal Health (CAH), and Zimmer Biomet (ZBH) poised for long-term…
Barchart · Oct 23, 2024 McKesson's Quarterly Earnings Preview: What You Need to Know With McKesson gearing up to release its second-quarter earnings next month, analysts expect a double-digit surge in earnings.
Barchart · Sep 20, 2024 Is Cardinal Health Stock Underperforming the Nasdaq? Despite Cardinal Health’s underperformance relative to the Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Barchart · Sep 12, 2024 Is McKesson Stock Underperforming the S&P 500? McKesson has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.
Barchart · Sep 10, 2024 How Is Cencora's Stock Performance Compared to Other Healthcare Stocks? Cencora has outperformed other healthcare stocks over the past year and analysts remain bullish about the stock’s prospects.
Barchart · Aug 26, 2024 McKesson Stock Outlook: Is Wall Street Bullish or Bearish? McKesson has outperformed the broader market this year, and Wall Street analysts are optimistic about the stock’s prospects.
Barchart · Aug 7, 2024 S&P Futures Climb as Risk Sentiment Improves, Disney Earnings on Tap September S&P 500 E-Mini futures (ESU24) are trending up +0.91% this morning, extending the rebound from Monday’s dramatic selloff, supported by remarks from a senior Bank of Japan official ruling out further rate hikes during periods of market instability, while investors awaited a new batch of earnings reports.
Barchart · Jul 22, 2024 McKesson's Q2 2024 Earnings: What to Expect With McKesson gearing up to release its first-quarter earnings next month, analysts project a single-digit earnings dip.
StockNews.com · Jul 16, 2024 With 25% YTD Gains, Is McKesson a Smart Investment Now? McKesson (MCK) reported consistent revenue growth and solid profit margins in the last reported quarter, supported by robust demand for pharmaceuticals and medical supplies and efficient cost management. With nearly 25% year-to-date gains, should you invest in this healthcare stock? Read on to learn more….
Barchart · Jul 1, 2024 2 'Strong-Buy' Rated Growth Stocks to Scoop Up Now There are good reasons to invest in the long-term potential of these growth stocks.
inkl · Jun 28, 2024 The iGaming consolidated in Canada after Ontario's model was found consistent with the Criminal Code by the Ontario Superior Court While changes to the iGaming market in Ontario were being heralded as a success by the province and commercial gambling operators alike, there has been a battle going on in the background.